欧盟、美国和加拿大批准了Galderma更新的Sestylane注射器,改进了设计、标签和生态友好包装。 The EU, U.S., and Canada approved Galderma’s updated Restylane syringes with better design, labeling, and eco-friendly packaging.

欧洲联盟、美国和加拿大已经批准了Galderma的新注射器设计,用于用于面部和手部治疗的NASHA Lidocaine内含Restylan的静脉注射器。 The European Union, U.S., and Canada have approved Galderma’s new syringe design for its NASHA lidocaine-containing Restylane injectables, used in facial and hand treatments. 升级的特点是人类工程学形状、改进针头连接、色标标签和100%的可再循环包装、提高精确度、使用方便度和可持续性。 The upgrade features an ergonomic shape, improved needle connection, color-coded labeling, and 100% recyclable packaging, enhancing precision, ease of use, and sustainability. 这一变化反映出美学技术的进步以及Galderma注重创新和环境责任。 The change reflects advancements in aesthetic technology and Galderma’s focus on innovation and environmental responsibility.